<?xml version='1.0' encoding='utf-8'?>
<document id="20223408"><sentence text="First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction."><entity charOffset="51-60" id="DDI-PubMed.20223408.s1.e0" text="methadone" /></sentence><sentence text="We describe the first case of stress cardiomyopathy secondary to a drug-drug interaction" /><sentence text=" A 44-year-old man was admitted for acute agitation, hallucinations, tachycardia, and fever within 2 hours of ingestion of naltrexone prescribed to stop alcohol consumption"><entity charOffset="123-133" id="DDI-PubMed.20223408.s3.e0" text="naltrexone" /><entity charOffset="153-160" id="DDI-PubMed.20223408.s3.e1" text="alcohol" /><pair ddi="false" e1="DDI-PubMed.20223408.s3.e0" e2="DDI-PubMed.20223408.s3.e0" /><pair ddi="false" e1="DDI-PubMed.20223408.s3.e0" e2="DDI-PubMed.20223408.s3.e1" /></sentence><sentence text=" He had been receiving methadone (120 mg/d) for several months for a history of heroin use; thus, acute opiate withdrawal syndrome secondary to naltrexone treatment was diagnosed"><entity charOffset="23-32" id="DDI-PubMed.20223408.s4.e0" text="methadone" /><entity charOffset="144-154" id="DDI-PubMed.20223408.s4.e1" text="naltrexone" /><pair ddi="false" e1="DDI-PubMed.20223408.s4.e0" e2="DDI-PubMed.20223408.s4.e0" /><pair ddi="false" e1="DDI-PubMed.20223408.s4.e0" e2="DDI-PubMed.20223408.s4.e1" /></sentence><sentence text=" Because electrocardiography showed diffuse ST-segment elevation, a transthoracic echocardiography was performed" /><sentence text=" It revealed apical akinesia of the left ventricle with a reduction in systolic function" /><sentence text=" The echocardiogram showed an ejection fraction of 35%, apical and midventricular wall motion abnormalities of the left ventricle, and a cardiac output of 4 L/min without coronary stenosis" /><sentence text=" The patient was transferred to the cardiologic intensive care unit with a diagnosis of transient left ventricular apical ballooning syndrome secondary to acute opiate withdrawal syndrome" /><sentence text=" It is likely that opioid withdrawal, inducing a marked increase in catecholamine plasma concentrations, contributed to the development of stress cardiomyopathy"><entity charOffset="19-25" id="DDI-PubMed.20223408.s9.e0" text="opioid" /><entity charOffset="68-81" id="DDI-PubMed.20223408.s9.e1" text="catecholamine" /><pair ddi="false" e1="DDI-PubMed.20223408.s9.e0" e2="DDI-PubMed.20223408.s9.e0" /><pair ddi="false" e1="DDI-PubMed.20223408.s9.e0" e2="DDI-PubMed.20223408.s9.e1" /></sentence><sentence text=" To our knowledge, this is the first case of stress cardiomyopathy described after abrupt opiate withdrawal secondary to a drug-drug interaction" /><sentence text="" /></document>